In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), invasive ...

A new study supports previous data demonstrating the superiority of prasugrel over ticagrelor in reducing the composite ...

Researchers have reported better long-term results of coronary artery bypass grafting (CABG) than of percutaneous coronary ...

AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 g/dL for the ...

The presence and clinical significance of hepatic tissue alterations as assessed by cardiac magnetic resonance imaging in patients with ST-segment–elevation myocardial infarction (STEMI), are unclear.

The primary objective of the SELECT trial was to demonstrate superiority of semaglutide 2.4 mg compared to placebo with respect to reducing the incidence of three-point MACE consisting of ...

The annual Esse Non Videri Gala Awards honors St. Joseph’s University alumni who, throughout their careers, have demonstrated their commitment to living the five St. Joseph’s University ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

1. If the Big Blue can spread the ball and find ways around the St. Benedict’s defense, it could have a chance at winning its first Non-Public A title since 2014. Perhaps the biggest thing coach ...

NEWARK — After St. Benedict's Prep defeated Delbarton, 4-0, in the NJSIAA Non-Public A North final on Friday night, athletic director Frank DiPiano gathered the players around him. Holding the ...

especially after a STEMI [ST-segment elevation MI]. And of course, it's very, very important to think about that in heart failure patients as well," Mehran said. CLEAR OASIS 9 enrolled patients ...

Patients with acute MI were randomized in 1:1 fashion to receive spironolactone 25 mg daily (n = 3,537) or placebo (n = 3,525) following PCI, preferably with the Boston Scientific SYNERGY ...